Interna Technologies B.V.
Records under this name other than the patents Interna Technologies B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 7 of 7 · Back to Interna Technologies B.V.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,174,314 | Mirna for Treating Head and Neck Cancer Formerly held In force · High confidence | In force | High confidence | |
| US 10,023,868 | Mirna for Treating Diseases and Conditions Associated with Neo-Angiogenesis Lapsed on the fee record Ended Jul 17, 2026 · High confidence | Lapsed on the fee record | Ended Jul 17, 2026 | High confidence |
| US 9,944,932 | MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT Lapsed on the fee record Ended Apr 17, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2026 | From the USPTO record |
| US 9,682,095 | MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway Lapsed on the fee record Ended Jun 20, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 20, 2025 | From the USPTO record |
| US 9,441,222 | MiRNA for Treating Diseases and Conditions Associated with Neo-angiogenesis Lapsed on the fee record Ended Sep 13, 2024 · High confidence | Lapsed on the fee record | Ended Sep 13, 2024 | High confidence |
| US 10,583,149 | MiRNA and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated BRAF pathway Lapsed on the fee record Ended Mar 10, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 10, 2024 | From the USPTO record |
| US 9,161,947 | MiRNA molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with EMT Lapsed on the fee record Ended Oct 20, 2023 · From the USPTO record | Lapsed on the fee record | Ended Oct 20, 2023 | From the USPTO record |